Business
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies.
About this update from Avenir Wellness Solutions Inc.
[{"type":"text","content":"\n\n LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will participate in an educational panel about cannabis science in Hawaii. This “Dinner & Dialogue” is put on by Lua Ola, Hawaii’s leading medical cannabis provider, and will address how to build a pharmaceutical cannabis system in the state. The panel will take place on Tuesday, March 27, in Honolulu, Hawaii.\n CURE is leveraging the synergism created by combining cannabinoids and terpenes into its advanced oral thin film, CUREfilm™, a proprietary polymer and encapsulation platform. CURE’s CEO, Robert Davidson will participate on the panel in Hawaii and will discuss the company’s pharmaceutical cannabinoid projects. “It is essential to share our knowledge and understanding on potential pharmaceutical cannabinoid drug formulations and delivery systems because many medical needs are not currently being met by traditional pharmaceuticals,” Davidson said. “This panel is made up of some of the leading minds in the field so we can work together to get FDA-approved drugs to market for those who need them.” Joining Davidson on this panel are other industry leaders and experts in the medical cannabis industry, including: Tracy Ryan, CEO of CANNAKIDS & Founder of SAVINGSOPHIE.org – In addition to being a member of CURE’s advisory board, Ryan has dedicated a huge part of her life to educating herself on the medicinal powers of medical marijuana in treating her own daughter’s disease, as well as all other pediatric and adult cancers, epilepsy, autism, and beyond.Joshua Crossney, President & Founder of JCANNA, Inc. – Crossney is working to bridge the gap between analytical sciences and the medical cannabis industry to help improve the quality of medicinal cannabis products being used by patients.Autumn Karcey, President of Cultivo Inc. – Karcey became passionate about creating optimal indoor environments where plants can be grown in a healthy, stable manner, free of pests and pathogens without the use of harmful pesticides and chemicals.Dr. Dedi Meiri from Israel Institute of Technology of Cancer Biology and Canna...